Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Hepatology (Baltimore, Md.)
|
March 20, 2009
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
Florin M Selaru, Alexandru V Olaru, Takatsugu Kan, et al.
Plos One
|
April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features
Fumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML
Nour Sabiha Naji, Taha Ahmedna, J David Peske, et al.
Blood Advances
|
May 20, 2026
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease
Nour Sabiha Naji, Taha Soueidatt Ahmedna, Xinghan Zeng, et al.
Haematologica
|
August 28, 2025
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Hepatology (Baltimore, Md.)
|
March 20, 2009
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
Florin M Selaru, Alexandru V Olaru, Takatsugu Kan, et al.
Plos One
|
April 3, 2008
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features
Fumiaki Sato, Zhe Jin, Karsten Schulmann, et al.
Biorxiv : the Preprint Server for Biology
|
September 2, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML
Nour Sabiha Naji, Taha Ahmedna, J David Peske, et al.
Blood Advances
|
May 20, 2026
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML including TP53-mutated disease
Nour Sabiha Naji, Taha Soueidatt Ahmedna, Xinghan Zeng, et al.
Haematologica
|
August 28, 2025
C-C motif chemokine receptor-like 2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Biorxiv : the Preprint Server for Biology
|
March 10, 2025
CCRL2 promotes the interferon-γ signaling response in myeloid neoplasms with erythroid differentiation and mutated <i>TP53</i>
Nour Sabiha Naji, Sergiu Pasca, Theodora Chatzilygeroudi, et al.
Page
of 3